Fractyl Health (GUTS) Operating Leases (2023 - 2026)
Fractyl Health's (GUTS) quarterly Operating Leases came in at $25.5 million in Q1 2026, down 5.58% YoY from $27.0 million in Q1 2025, and down 1.6% on a QoQ basis from $26.0 million in Q4 2025.
Fractyl Health (GUTS) Operating Leases (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Operating Leases data on file, last reported at $25.5 million in Q1 2026.
- Quarterly Operating Leases fell 5.58% year-over-year to $25.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.5 million (down 5.58% YoY) and the FY2025 annual result came in at $26.0 million, down 5.21% from the prior year.
- Operating Leases retreated to $25.5 million in Q1 2026, from $26.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $28.5 million in Q4 2023 to a low of $25.5 million in Q1 2026.
- A 4-year average of $27.1 million and a median of $27.2 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases decreased 3.95% — and 2026, when it decreased 5.58%.
- Tracing GUTS's Operating Leases over 4 years: stood at $28.5 million in 2023, then decreased by 3.95% to $27.4 million in 2024, then slipped by 5.21% to $26.0 million in 2025, then slipped by 1.6% to $25.5 million in 2026.
- The last three Operating Leases figures came in at $25.5 million (Q1 2026), $26.0 million (Q4 2025), and $26.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.11 Mn |
| Mar 31, 2026 | 25.54 Mn |
| Dec 31, 2025 | 25.96 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Jun 30, 2025 | 26.70 Mn |
| Mar 31, 2025 | 27.05 Mn |
| Dec 31, 2024 | 27.38 Mn |
| Sep 30, 2024 | 27.69 Mn |
| Jun 30, 2024 | 27.97 Mn |
| Mar 31, 2024 | 28.25 Mn |
| Dec 31, 2023 | 28.51 Mn |